Bioxcel therapeutics to present at the h.c. wainwright 27th annual global investment conference

New haven, conn., sept. 04, 2025 (globe newswire) -- bioxcel therapeutics, inc. (nasdaq: btai), a biopharmaceutical company utilizing artificial intelligence to develop transformative medicines in neuroscience, today announced that vimal mehta, ph.d.
BTAI Ratings Summary
BTAI Quant Ranking